Company
United StatesPublic company, NASDAQ: ACADAcadia Pharmaceuticals Inc. (NASDAQ: ACAD), San Diego, CA – FDA Inspections
Inspection records and compliance data for Acadia Pharmaceuticals Inc. in San Diego, California. 2 FDA inspections on record, last inspected January 27, 2021. Publicly traded as NASDAQ: ACAD.
Company Profile
This profile covers Acadia Pharmaceuticals Inc. based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
First inspected February 17, 2016. Last inspected January 27, 2021.
Most cited issue areas
- General responsibilities of sponsors1 inspection
- Monitoring investigations1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 27, 2021 | VAI | Human Drugs · Bioresearch Monitoring | 1135361 |
| February 17, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 965150 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Acadia Pharmaceuticals Inc.
Stock ticker
ACAD
Exchange
NASDAQ
Share price
$21.20
Market cap
$3.7B
Price as of
November 6, 2026
FEI Number
3005617555
Address
12830 El Camino Real Ste 400, San Diego, California 92130, United States
Country
United States
ID: 28c1a8c0-e128-4d10-ac29-27aa95b67b55